Your browser doesn't support javascript.
loading
Refractory chronic spontaneous urticaria after the use of alemtuzumab in multiple sclerosis.
Hu, Hannah; Reddell, Stephen; Riminton, Sean; Chan, Charles; Urriola, Nicolás.
Afiliação
  • Hu H; From the Concord Repatriation General Hospital (H.H.); Brain and Mind Research Institute (S. Reddell), University of Sydney, Concord Repatriation General Hospital; and University of Sydney (S. Riminton, C.C., N.U.), Concord Repatriation General Hospital, Australia. hannah.hu@health.nsw.gov.au.
  • Reddell S; From the Concord Repatriation General Hospital (H.H.); Brain and Mind Research Institute (S. Reddell), University of Sydney, Concord Repatriation General Hospital; and University of Sydney (S. Riminton, C.C., N.U.), Concord Repatriation General Hospital, Australia.
  • Riminton S; From the Concord Repatriation General Hospital (H.H.); Brain and Mind Research Institute (S. Reddell), University of Sydney, Concord Repatriation General Hospital; and University of Sydney (S. Riminton, C.C., N.U.), Concord Repatriation General Hospital, Australia.
  • Chan C; From the Concord Repatriation General Hospital (H.H.); Brain and Mind Research Institute (S. Reddell), University of Sydney, Concord Repatriation General Hospital; and University of Sydney (S. Riminton, C.C., N.U.), Concord Repatriation General Hospital, Australia.
  • Urriola N; From the Concord Repatriation General Hospital (H.H.); Brain and Mind Research Institute (S. Reddell), University of Sydney, Concord Repatriation General Hospital; and University of Sydney (S. Riminton, C.C., N.U.), Concord Repatriation General Hospital, Australia.
Article em En | MEDLINE | ID: mdl-31915266

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alemtuzumab / Urticária Crônica / Fatores Imunológicos / Esclerose Múltipla Limite: Adult / Female / Humans Idioma: En Revista: Neurol Neuroimmunol Neuroinflamm Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Alemtuzumab / Urticária Crônica / Fatores Imunológicos / Esclerose Múltipla Limite: Adult / Female / Humans Idioma: En Revista: Neurol Neuroimmunol Neuroinflamm Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Austrália